Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great input. The issue is perception. The great unwashed investor pool, including me have a perception of That area that's not good. I accept that I have not been there in 23 years and know nothing about the medical advances in the area but perception will drive investor decisions
Not important. What is important is a catylist to get the SP up.That means much higher volume and credibility from BP , the NIH or other significant heavily market monitored group. A string of good news that includes ODD approval, IND number for tcell, positive update on Dcell, and positive progress update from NCI would serve to change the SP direction. While this news is welcome and this institution has a good reputation Mexico and Tijuiana simply don't inspire a vision of rigorous medicine. Lander is running on the outside lane and needs to move to the inside if he wants to win this race.
If it wasn't for the discounted shares and 30 million in pref shares Id be fine waiting for the company to report when they're ready, but they dropped those turds on us over the last month and I'm pissed off. I've invested a lot of money that's helped keep them going and I'm losing patience as they dilute me away. If an influx of tweets and emails helps to stop the discounting, that's a big win.
Good point. My concern is that Lander doesn't read the Twitter account but he does read his emails. So, both efforts might get their attention.
I email Harry Lander almost every day now. He no longer responds but he gets the email and I know it adds to the pressure to perform. My emails are more direct now that they've issued 30 million pref shares to themselves and continued with the deep discounts to friends and family. I say each and every long on this board sends him a message every day demanding progress updates. It's been 7 weeks since we got an update on any of their projects.
Harry.Lander@regenbiopharma.com
That's only half the right question. The other half is how long should it take a biotech pharma to succeed. It its all about getting drugs to market via FDA approval then the FDA quoted 4 to 7 years from application to Phase 3 acceptance. Regen is in year 4 and has 3 or 4 drugs in the pipeline.
This is also the OTC where investors are gamblers looking for the big hit. You want safer? Go to NYSE or NASDAQ.
It's also one of the few places where a startup can get financing AND keep control. So, until the big hit the owner's sell stock. Wow, what a revelation.
The Big SP gain is all about selling the drug or company or licensing to a monied BP. If RGBP can license or sell all or 1 of their products this year, the SP will skyrocket and Koos and company will be deemed successful.
Pump and hype by Management ineffective.
I'd prefer to see a partnership deal with BP.
The dividend is not an obligation.
BMSN went from .001 to .016 and then from .0013 to .09. RGBP went from .08 to .45 last March. And those runs were on less dramatic news then we're waiting for so it can and WILL happen
SP increases will occur with PRs that have some reasonable non dilutive financing, or revenue generating opportunity. I'm optimistic that if we get Orphan status the possibility of grant funding and a faster path to market will bring in new investors. It's worked for many but NOT ALL biotechs. Strong NCI progress may also attract investors. Of course real concrete dollars from BP would be the surest rocket fuel.
To answer your question I have seen many PRs do nothing but disappoint and the SP suffer.
SP increases will occur with PRs that have some reasonable non dilutive financing, or revenue generating opportunity. I'm optimistic that if we get Orphan status the possibility of grant funding and a faster path to market will bring in new investors. It's worked for many but NOT ALL biotechs. Strong NCI progress may also attract investors. Of course real concrete dollars from BP would be the surest rocket fuel.
To answer your question I have seen many PRs do nothing but disappoint and the SP suffer.
So much activity on Dcell, ODD, NCI, Lilly, Tcell IND number, 4th IND, research funded by FF discounts alluded to in Lander response to me, partnerships and collaborations, possible grant and other funding and a general update on overall progress. Something or a lot of something will be popping up in PRs.
So much activity on Dcell, ODD, NCI, Lilly, Tcell IND number, 4th IND, research funded by FF discounts alluded to in Lander response to me, partnerships and collaborations, possible grant and other funding and a general update on overall progress. Something or a lot of something will be popping up in PRs.
Looks like pref moving up and common recovering.
I'm at a loss for why this has come out so low.
Anything under the common's price is a steal.
Makes no sense to me. The ask is at .05. It should be 10 times that.
I know who's selling. But, who's buying?
And Me.
The radio silence is hopefully evidence that Lander is finalizing some serious partnerships.
I think Barton is selling shares to anyone willing to buy at .0001.
New 8k with real SP value creation tomorrow morning?
I believe the opposite. They've diluted to no bid. If they want to cash in on unsuspecting new investors they need to Reverse Split and start a new round of pumping.
10 million each for 3 people.
Its so obvious what's happening. The company is selling shares and diluting like crazy. It's now reached no bid and will require a reverse split. Any news will be accompanied by more dilution.
I'm with you on all points except...30 million pref shares. C'mon.
Nice finish. 75k on bid at 11.5. Big week next week.
Volume before price. The volume the past three days has been interesting.
I've sent a few messages. None was a threat but I voiced my displeasure at the size of the bonuses and the apparent lack of value created by Caven over the last year. Glad you had a conversation. Was that before he was threatened with legal action? Did he offer anything of interest?
OS will be over 2 billion when next Q is issued. Sales less than 15k. My prediction.
I agree. 30 million is obscene and unwarranted. I only hope that they believe they'll each make 100 million on a huge sale.
They need to have the share structure set prior to a deal with BP. That's my only rationale for the 30 million shares. I'm hoping that the delay in share trading on the pref shares is a huge value creation announcement.
Wow, CV I completely disagree. It was painful but the Hema process was as transparent as could have been reasonably possible. From submission, to FDA questions, to additional experiments, to approval of all but safety, to clarification on needing GLP lab, to submission of safety protocol, to selection of GLP lab, to early GLP results, to submission of final safety results to approval. And I've been here since March 2013.
Dcell seems to be going through the same FDA back and forth.
The biggest and only issue I have is the cavalier attitude towards self dealing. But 10 million shares of pref shares is worth a lot more at $5 than .50, so they are motivated to maximize value. IMO threatening a lawsuit in the note to Lander was imprudent. He has now shut down all responses to investors and cut off that opportunity for clarifications. And, I don't blame him.
I've sent 3 notes to Lander and he's just not replying. I imagine he's got the message that we need an update. Today's volume and uptick from the bottom is perplexing and could mean many things, including something good. All very confusing. A lot of mixed messages.
Or how about just selling 90000 into the market at .11. That way there is no one with a discounted basis and the company gets funded with minimal reasonable dilution.
Not 15 cents .0015. My mistake.
So, let me get this straight. You kept BMSN and sold RGBP. Let me stop laughing first. For the record I sold BMSN at about 15 cents 18 months ago. And bought RGBP with those proceeds to add to my divy shares. Then last year received my 110,000 pref shares. I suppose the next few months will tell who made the right decision but it appeared to me that the company was almost screaming that the ticket they were protecting was RGBP not BMSN. I actually think BMSN will partially recover in some way. GLTA
Please. Save your advice for those who care. I believe the SP here will soar. You may want to buy in a these basement prices.
Share price multiplied by the number of shares you own equals zero. So why bother? The only dip here is the one I'm responding to.